Differential production of γδ T cells in the urine of bladder cancer patients receiving bacillus Calmette Guerin immunotherapy

International Journal of Oncology

Volumn 10, Issue 2, 1997, Pages 387-393

  Alexandroff, Anton Benjamin ^a   Black, James ^a   Bollina, Presad Ramachandra ^a   James, Keith ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

T lymphocytes; BCG immunotherapy; bladder neoplasms

Indexed keywords

BCG VACCINE; MONOCLONAL ANTIBODY;

ARTICLE; BLADDER CANCER; CANCER CELL; CANCER IMMUNOTHERAPY; FLUORESCENCE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SOLID TUMOR; T LYMPHOCYTE;

EID: 0031043796     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lamm DL, Griffith G, Pettit LL and Nseyo UO: Current perspectives on diagnosis and treatment of superficial bladder cancer. Urology 39: 301-308, 1992.
2. Lamm DL, van der Meijden PM, Morales A, Brosman SA, Catalona WJ, Herr HW, Soloway MS, Steg A and Debruyne FMJ: Incidence and treatment of complications of bacillus Calmette Guerin intravesical therapy in superficial bladder cancer. J Urol 147: 596-600, 1992.
3. Jackson AM and James K: Understanding the most successful immunotherapy for cancer. Immunologist 2: 208-215, 1994.
4. Alexandroff AB, Jackson AM, Skibinska A and James K: Production of IL-5, a classical T(H)2 cytokine, following BCG immunotherapy of bladder cancer. Int J Oncol 9: 179-182, 1996.
5. Alexandroff AB, Jackson AM, Skibinska A, Young DG, McIntyre M, Prescott S and James K: Bladder cancer cells do not express co-stimulatory molecules B7-1, B7-2 and B7-3. Evidence for the existence of an additional ligand for LFA-1. Int J Oncol 8: 1273-1282, 1996.
6. Alexandroff AB, Jackson AM, Chisholm GD and James K: Cytokine modulation of epidermal growth factor receptor expression on bladder cancer cells is not a major contributor to the antitumour activity of cytokines. Eur J Cancer 31A: 2059-2066, 1995.
7. Alexandroff AB, Jackson AM, Esuvaranathan K, Prescott S and James K: Autocrine regulation of ICAM-1 expression on bladder cancer cell-lines: evidence for the role of IL-1 alpha. Immunol Lett 40: 117-124, 1994.
8. Jackson AM, Alexandroff AB, Fleming D, Prescott S, Chisholm GD and James K: BCG organisms directly alter the growth of bladder tumour cells. Int J Oncol 5: 697-703, 1994.
9. Jackson AM, Alexandroff AB, McIntyre M, Esuvaranathan K, James K and Chisholm GD: Induction of ICAM-1 expression on bladder tumours by BCG immunotherapy. J Clin Pathol 47: 309-312, 1994.
10. Jackson AM, Alexandroff AB, Kelly RW, Skibinska A, Esuvaranathan K, Prescott S, Chisholm GD and James K: Changes in urinary cytokines and sICAM-1 in bladder cancer patients after BCG immunotherapy. Clin Exp Immunol 99: 369-375, 1995.
11. Alexandroff AB: Once more into the breach. Inaugural meeting of the British Society of Immunology Tumour Immunology Affinity Group. Cancer Immunol Immunother (In press).
12. Alexandroff AB, Black J, Esuvaranathan K and James K: Antiproliferative effect of IL-6 on transitional cell carcinoma of the bladder. Insight into mechanisms of bacillus Calmette Guerin immunotherapy. Biochem Soc Trans (In press).
13. Haas W, Pereira P, Tonegawa S: Gamma/delta cells. Annu Rev Immunol 11: 637-685, 1993.
14. Kabelitz D: Role of gamma/delta T cells in the immune response against tumour cells. J Cancer 8: 190-194, 1995.
15. Ferrarini M, Heltai S, Pupa SM, Menard S and Zocchi MR: Killing of laminin receptor-positive human lung cancers by tumour-infiltrating lymphocytes bearing γδ+ T cell receptor. J Natl Cancer Inst 88: 436-441, 1996.
16. Tanaka Y, Sano S, Nieves E, De Libero G, Rosa D, Modlin RL, Brenner MB, Bloom BR and Monta GT: Nonpeptide ligands for human gamma/delta T cells. Proc Natl Acad Sci USA 91: 8175-8179, 1994.
17. Burk MR, Mori L and De Libero G: Human Vγ9-Vδ2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites. Eur J Immunol 25: 2052-2058, 1995.
18. Constant P, Poquet Y, Peyrat M-A, Davodeau F, Bonneville M and Fournie J-J: The antituberculous Mycobacterium bovis BCG vaccine is an attenuated mycobacterial producer of phosphorylated nonpeptidic antigens for human γδ cells. Infect Immun 63: 4628-4633, 1995.
19. Pechhold K, Wesch D, Schondelmaier S and Kabelitz D: Primary activation of V gamma 9-expressing gamma delta T cells by Mycobacterium tuberculosis. Requirement for Th1-type CD4 T cell help and inhibition by IL-10. J Immunol 152: 4984-4992, 1994.
20. Richards EH, Hickman JA and Masters JR: Heat shock protein expression in testis and bladder cancer cell lines exhibiting differential sensitivity to heat. Br J Cancer 72: 620-626, 1995.
21. + lymphocytes by sonicated antigens of Mycobacterium tuberculosis: role in vitro in killing human bladder carcinoma cell lines. Scand J Immunol 38: 239-249, 1993.
22. Bruno S, Machi AM, Semino C, Meta M, Ponte M, Varaldo M, Curotto A, Ferlazzo G, Decensi A and Melioli G: Phenotypic, functional and molecular analysis of lymphocytes associated with bladder cancer. Cancer Immunol Immunother 42: 47-54, 1996.
23. de Boer EC, de Jong WH, Van Der Meijden APM, Steerenberg PA, Witjes JA, Vegt PDJ, Debruyene FMJ and Ruitenberg EJ: Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with BCG. Cancer Immunol Immunother 33: 411-416, 1991.
24. Deterre P, Gelman L, Gouy H, Arrieumerlou C, Berthelier V, Tixie JM, Ktorza S, Goding J, Schmitt C and Bismuth G: Coordinated regulation in human T cells of nucleotide-hydrolyzing ecto-enzymatic activities, including CD38 and PC-I. J Immunol 157: 1381-1388, 1996.
25. Spaner D, Cohen BL, Miller RG and Phillips RA: Antigen-presenting cells for naive transgenic gamma delta T cells. Potent activation by activated alpha beta T cells. J Immunol 155: 3866-3876, 1995.
26. Skccn MJ and Ziegler HK: Activation of γδ T cells for production of IFN-γ is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12. J Immunol 154: 5832-5841, 1995.
27. Nishimura H, Hiromatsu K, Kobayashi N, Grabstein KH, Paxton R, Sugamura K, Bluestone JA and Yoshikai Y: IL-15 is a novel growth factor for murine γδ T cells induced by Salmonella infection. J Immunol 156: 663-669, 1996.
28. + T lymphocytes recognize tumour cells of epithelial origin. J Exp Med 183: 1681-1696, 1996.
29. + T lymphocytes. J Immunol 151: 6043-6050, 1993.
30. - T cells: B7-independent costimulation of CD1-restricted T cells. J Exp Med 182: 2007-2018, 1995.
31. Bendelac A: CD1: presenting unusual antigens to unusual T lymphocytes. Science 269: 185-186, 1995.
32. Alexandroff AB, Mitchel I, Black J and James K: Is the success of BCG tumour immunotherapy due to the induction of costimulatory molecules? Biochem Soc Trans (In press).
33. Nakajima S, Roswit TW, Look DC and Holtzman MJ: A hierarchy for integrin expression and adhesiveness among T cell subsets that is linked to TCR gene usage and emphasizes Vδ1 γδ T cell adherence and tissue retention. J Immunol 155: 1117-1131, 1995.